Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
5 things to know before the stock market opens Tuesday
Tags Business Eisai Co Ltd Tesla Inc
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
Tags Science US: News Eli Lilly and Co
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
Tags Breaking News: Business Business News Medicare health plans
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Tags Health care industry Biogen Inc Alzheimer's disease
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
Tags Rivian Automotive Inc Markets Economy
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
Tags Markets Economy Finance
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
Tags Biotech and Pharmaceuticals Pharmaceuticals Biogen Inc
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
Tags Health care industry Biogen Inc Alzheimer's disease
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
Tags Oracle Corp Halliburton Co Norwegian Cruise Line Holdings Ltd
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
Tags Breaking News: Business Business News Epidemics
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags Biogen Inc Alzheimer's disease U/S/ Economy
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
Tags TJX Companies Inc Food and Beverage Investing
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Eli Lilly and Co Policy US: News
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
Tags Markets PacWest Bancorp Western Alliance Bancorp
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
Tags Health & Science Business Biotechnology
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
Tags CVS Health Corp Quanterix Corp US Top News and Analysis
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
Tags US: News Policy Eisai Co Ltd
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Health & Science Biotechnology Business
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
Tags Health & Science Biotechnology Science
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Tags Breaking News: Business Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
Tags Breaking news Companies Health care industry
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
Tags Health care industry Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
Tags Biogen Inc Health care industry Companies
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
Tags Policy US: News Health & Science
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
Tags US Economy World News Politics
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
Tags Health & Science Eisai Co Ltd Business
From CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
Tags Bio Rad Laboratories Inc Biogen Inc Deere & Co
From CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
Tags US: News Policy Health & Science
From CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
Tags US Economy Politics World News
From CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
Tags Breaking News: Markets stocks FactSet Research Systems Inc
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.